Retatrutide is a new medication in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, https://lawsonxkzq673493.arwebo.com/58646546/tirzepatide-a-promising-new-treatment-for-obesity